Dr. Suvannasankha is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
980 West Walnut Street, Rm 312
Indianapolis, IN 46202Phone+1 317-274-0843Fax+1 317-274-0936- Is this information wrong?
Education & Training
- University at BuffaloFellowship, Hematology and Medical Oncology, 2000 - 2003
- Albert Einstein Healthcare NetworkResidency, Internal Medicine, 1997 - 2000
- Chulalongkorn University Faculty of MedicineClass of 1996
Certifications & Licensure
- IN State Medical License 2003 - 2023
- PA State Medical License 1998 - 2000
- American Board of Internal Medicine Hematology
Clinical Trials
- Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma Start of enrollment: 2005 Jun 01
- Phase II Study of Revlimid®, Oral Cyclophosphamide and Prednisone for Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2007 Oct 01
- Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple Myeloma Start of enrollment: 2010 Aug 27
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsEfficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents.Adam D Cohen, María-Victoria Mateos, Yael C Cohen, Paula Rodriguez-Otero, Bruno Paiva, Niels W C J van de Donk, Thomas Martin, Attaya Suvannasankha, Kevin C De Braganc...> ;Blood. 2023 Jan 19
- 1 citationsGFI1-Dependent Repression ofIncreases Multiple Myeloma Cell Survival.Daniela N Petrusca, Patrick L Mulcrone, David A Macar, Ryan T Bishop, Evgeny Berdyshev, Attaya Suvannasankha, Judith L Anderson, Quanhong Sun, Philip E Auron, Deborah ...> ;Viszeralmedizin 2021 Gemeinsame Jahrestagung Deutsche Gesellschaft Für Gastroenterologie, Verdauungs- Und Stoffwechselkrankheiten. 2022 Feb 2
- 2 citationsDREAMM-2: Indirect Comparisons of Belantamab Mafodotin vs. Selinexor + Dexamethasone and Standard of Care Treatments in Relapsed/Refractory Multiple Myeloma.Thibaud Prawitz, Rakesh Popat, Attaya Suvannasankha, Grammati Sarri, Rachel Hughes, Feng Wang, Cosmina Hogea, Shannon Ferrante, Boris Gorsh, Jenny Willson, Venediktos ...> ;Advances in Therapy. 2021 Sep 24
- Join now to see all
Press Mentions
- Purdue Researchers at Work on Anemia App to Make Detection EasierNovember 30th, 2017
- Early Data Indicates New Therapy Is ‘Safe and Effective’ for Cancer Metastases in BonesApril 30th, 2021
Professional Memberships
- Member
Hospital Affiliations
- Select Specialty Hospital of INpolisIndianapolis, Indiana
- Eskenazi HealthIndianapolis, Indiana
- Richard L. Roudebush Veterans Affairs Medical CenterIndianapolis, Indiana
- Indiana University Health University HospitalIndianapolis, Indiana
- Indiana University Health North HospitalCarmel, Indiana
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: